about
Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure ratsDysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure.Plasma cytokine profile in tropical endomyocardial fibrosis: predominance of TNF-a, IL-4 and IL-10.Cardiac impairment evaluated by transesophageal echocardiography and invasive measurements in rats undergoing sinoaortic denervationNoncompaction cardiomyopathy: a substrate for a thromboembolic eventDysregulation of Autonomic Nervous System in Chagas' Heart Disease Is Associated with Altered Adipocytokines Levels.Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy.Exercise training prevents diastolic dysfunction induced by metabolic syndrome in ratsThe effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy.Endothelial and non-endothelial coronary blood flow reserve and left ventricular dysfunction in systemic hypertension.Left ventricular basal region involvement in noncompaction cardiomyopathy.Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents.Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats.Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease.Homocysteine thiolactone induces cardiac dysfunction: role of oxidative stress.Quantification of regional left and right ventricular deformation indices in healthy neonates by using strain rate and strain imaging.Sequential changes of longitudinal and radial myocardial deformation indices in the healthy neonate heart.N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes.Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies.[NT pro-BNP levels in pericardial diseases and how they are used as complementary evaluation method of diastolic restriction. Initial experience: 25 cases].Leptin levels in different forms of Chagas' disease.TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy.Aldosterone antagonism in an inflammatory state: evidence for myocardial protection.The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis.Echocardiographic predictors of functional capacity in endomyocardial fibrosis patients.Response to Letters Regarding Article, “Ten-Year Incidence of Chagas Cardiomyopathy Among Asymptomatic, Trypanosoma cruzi –Seropositive Former Blood Donors”Effects of the association of diabetes and pulmonary emphysema on cardiac structure and function in ratsDifferential effects of variation in athletes training on myocardial morphophysiological adaptation in men: Focus on 123I-MIBG assessed myocardial sympathetic activityMassive Left Ventricular Calcification: Related to Endomyocardial Fibrosis or Idiopathic?Cardiac and pulmonary arterial remodeling after sinoaortic denervation in normotensive ratsPulmonary hypertension diagnosed by right heart catheterisation in sickle cell diseaseType III glycogen storage disease mimicking hypertrophic cardiomyopathyLate Gadolinium Enhancement Magnetic Resonance Imaging in the Diagnosis and Prognosis of Endomyocardial Fibrosis PatientsSubclinical Regional Left Ventricular Dysfunction in Obese Patients With and Without Hypertension or HypertrophyRelationship Between Outflow Obstruction and Left Ventricular Functional Impairment in Hypertrophic Cardiomyopathy: A Doppler Echocardiographic StudyUsefulness of a New Proposed Tissue Doppler Imaging Global Function Index in Hypertrophic CardiomyopathyRecovery of systolic and diastolic function after ablation of incessant supraventricular tachycardiaAssessment of Diastolic Function in Endomyocardial Fibrosis: Value of Flow Propagation VelocityEchocardiographic Assessment of Global Ventricular Function Using the Myocardial Performance Index in Rats with Hypertrophy849-4 Soluble tumor necrosis factor receptor (etanercept) treatment enhances left ventricular dysfunction in an experimental model of chronic chagas disease cardiomyopathy
P50
Q33654750-238F8515-A443-401C-9D0F-DBFE23EA8978Q33725534-861FC530-0FB7-4F44-BD2F-7C5A40CE731AQ34323604-3C45977C-2034-4241-B6B1-E424E728930EQ35168754-E7E427B9-FFD7-416A-94D8-43762CF4DFB8Q35548645-57A838DF-5CBA-4CA8-B75C-8DDEACDFC54FQ35683266-D1767FBD-3F6F-4F2D-9054-B0C925D44311Q35911618-04FC388B-6BB9-4D3F-8A8A-68AD952BDA3DQ36104100-70DEF7B1-844F-409B-92A9-AA21129CD402Q36223002-79F2B936-A1EA-4DF8-8493-1C76249F2776Q37222753-74BB826E-A842-4BCD-9F6E-DFCF16B0F846Q38116702-5A4D5394-B9B0-4191-A08C-81729E3FE433Q42010873-386950F9-B1D9-4294-A01A-71E398D44333Q42025175-84B2405B-6EAC-436A-8492-0A52FA1FB6DEQ42949885-DD5858D7-B73A-412B-A5A5-0BBE474E3BB2Q43221961-57C1A894-6226-4480-A9E6-031065015885Q44908641-43E729E2-F3FC-4318-BDF0-6297897379A8Q46179722-529DE37D-D7AD-46BE-8122-A381C655C71BQ48922528-A628BD03-CE8F-4A96-9265-0FF7919239CEQ49033525-7439407B-23D2-4BE8-9FE4-68831485DDCAQ50093668-F5EC4379-95F2-46D7-9CEC-A466605539D5Q51465133-0DBCCA07-FEE7-4EE7-9E1C-F0E60F9EDAD1Q51795933-32FB3F3C-49FC-4101-B73F-2E8A54FD2998Q51802362-B7383A52-43CC-4845-B335-01CB1AB2F40AQ51833009-32E3EBB2-5DD5-4747-A6EC-7C28D8C59275Q54449324-53E7A4AD-0C67-4D91-A5BF-5F71C1AA2EC4Q58847558-159FC0FB-2AAE-4D9F-836A-8D4A960285D7Q58853825-BB40D47B-650B-4C41-810C-4B0B290362EBQ58862349-F6417795-F880-4FBE-9E4A-329CE91ACAC0Q58862350-127E3D4D-9992-4A0C-9A97-22B8B7F42DFBQ58862356-76B2DC26-BDB0-4C2B-B35C-6E884AEA735DQ58862358-613CD7A7-D0EE-481A-A771-7F3CA62A232FQ58862361-9CEF8FA6-9711-4B05-933E-A7489D2CCBACQ58862365-7C09EAF2-9229-494A-9460-EEC6ADD0AC9BQ58862367-BD2E321B-47B1-48B1-93F4-9792AD03D2BEQ58862386-273E4B5A-788A-41E8-9E7F-8E7DD2DA143CQ58862388-5D315B94-1DFE-4B8E-99B6-DA3B1CFAEACAQ58862393-70B396E9-6D01-4DF8-8736-B44C096994B9Q58862397-07284758-8BCE-4677-B7CE-DC38CB691DD1Q58862399-47E5D7AA-C338-4903-9E93-6E420A44D87CQ58862401-E4374673-BFD5-4EA8-B13D-E3291C40ACA9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vera M Salemi
@ast
Vera M Salemi
@en
Vera M Salemi
@es
Vera M Salemi
@nl
type
label
Vera M Salemi
@ast
Vera M Salemi
@en
Vera M Salemi
@es
Vera M Salemi
@nl
prefLabel
Vera M Salemi
@ast
Vera M Salemi
@en
Vera M Salemi
@es
Vera M Salemi
@nl
P1053
C-9104-2013
P106
P21
P31
P3829
P496
0000-0002-7152-1810